Equity Details
Price & Market Data
Price: $0.252
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $401,714,240
Daily Volume: 0
Performance Metrics
1 Week: 14.32%
1 Month: 23.89%
3 Months: -4.34%
6 Months: 2.65%
1 Year: -10.78%
YTD: 9.97%
About Northwest Biotherapeutics, Inc. (NWBO)
Get the latest on Northwest Biotherapeutics, Inc. (NWBO). Priced at 0.252, with a daily shift of $0.00 / 0.00%. Market cap: 401,714,240. Crucial performance data includes YTD (9.97%) and 1-month (23.89%) returns.
Company Details
Employees: 25
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Northwest Biotherapeutics, Inc., a biotechnology company, focuses on developing personalized immune therapies for cancer. The company develops DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product candidate is the DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, that has completed Phase I clinical trials to treat inoperable solid tumors, as well as a range of types of cancers. Northwest Biotherapeutics, Inc. was founded in 1996 and is headquartered in Bethesda, Maryland.